-

Shareholder Alert: Robbins LLP Announces It Is Investigating Alpha and Omega Semiconductor Limited (AOSL) for Misleading Shareholders

SAN DIEGO & HAMILTON, Bermuda--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that it is investigating Alpha and Omega Semiconductor Limited (NASDAQ: AOSL) for alleged violations of the Securities Exchange Act of 1934 and whether the Company's officers and directors breached their fiduciary duties to shareholders. Alpha and Omega designs, develops, and supplies power semiconductor products for computing, consumer electronics, communication, and industrial applications worldwide.

If you suffered a loss as a result of Alpha and Omega's misconduct, click here.

Alpha and Omega Semiconductor Limited (AOSL) Reveals DOJ Investigation

In August 2019, Alpha and Omega filed its full year 2019 financial results, assuring that "despite the ongoing challenges of current market conditions… [the Company] is consistently making progress toward [its] calendar 2021 annual revenue target of $600 million." Then, On February 5, 2020, Alpha and Omega revealed that the U.S. Department of Justice "recently commenced an investigation into the Company's compliance with export control regulations with Huawei and its affiliates" and went on to disclose that as a result, the Department of Commerce had requested a suspension of its product shipments to Huawei, which would consequently reduce revenue by approximately $4 million to $5 million in the March quarter. On this news, Alpha and Omega's stock price fell almost 12% to close at $10.85 per share.

Alpha and Omega Semiconductor Limited (AOSL) Shareholders Have Legal Options

Contact us to learn more:
Leo Kandinov
(800) 350-6003
lkandinov@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. Click here to receive free alerts from Stock Watch when companies engage in wrongdoing.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
lkandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:AOSL

Release Versions
$Cashtags

Contacts

Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
lkandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Robbins LLP Urges Investors Who Lost Money Investing in Upstart Holdings, Inc. to Contact the Firm for Information About Leading the Class Action Against UPST

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Upstart Holdings, Inc. (NASDAQ: UPST) securities between May 14, 2025 and November 4, 2025. Upstart, together with its subsidiaries, operates a cloud-based artificial intelligence (“AI”) lending platform in the U.S.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.What is the class period?...

Robbins LLP Urges Investors Who Lost Money Investing in Stellantis N.V. to Contact the Firm for Information About Leading the Class Action Against STLA

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Stellantis N.V. (NYSE: STLA) securities between February 26, 2025 and February 5, 2026. Stellantis is a global automobile designer, engineer, manufacturer, and distributor.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.What is the class period? February 26, 2025 – February 5, 2026What a...

Robbins LLP Urges Investors Who Lost Money Investing in Medpace Holdings Inc. to Contact the Firm for Information About Leading the Class Action Against MEDP

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Medpace Holdings Inc. (NASDAQ: MEDP) securities between April 22, 2025 and February 9, 2026. Medpace is a clinical contract research organization (CRO) focused on providing scientifically driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries.For more information, submit a form, email...
Back to Newsroom